HCA Healthcare, Inc.(HCA)Earnings, Financials & Key RatiosHCA Healthcare, Inc. (HCA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the combination of a negative $6.3B equity base and a compressed 4.7% free cash flow margin suggests significant long-term solvency and operational risks that outweigh the current 13.80 P/E valuation.
HCA Healthcare, Inc. (HCA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
HCA Healthcare, Inc. (HCA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 24, 2026 | $7.15vs $7.12+0.4% | $19.1Bvs $19.1B+0.1% |
| Q1 2026 | Jan 27, 2026 | $8.01vs $7.46+7.4% | $19.5Bvs $19.7B-0.9% |
| Q4 2025 | Oct 24, 2025 | $6.96vs $5.79+20.2% | $19.2Bvs $18.6B+3.0% |
| Q3 2025 | Jul 25, 2025 | $6.84vs $6.29+8.7% | $18.6Bvs $18.5B+0.6% |
Recent stock market news and headlines for HCA Healthcare, Inc. (HCA)
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Key metrics vs top competitors for HCA Healthcare, Inc. (HCA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $423.11 | $93.86B | 14.91 | 7.08% | 8.97% | — | 0.7% | |
| $191.20 | $16.75B | 12.34 | 3.12% | 7.94% | 19.56% | — | |
| $3.82 | $538.36M | 1.01 | -1.18% | -0.41% | — | — | |
| $161.26 | $10.09B | 6.98 | 9.71% | 8.56% | 20.65% | — | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $16.51 | $2.05B | 13.99 | 5.12% | 2.42% | 6.57% | — |
HCA Healthcare, Inc. (HCA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HCA Healthcare, Inc. (HCA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jun 18, 2026·SEC
Apr 30, 2026·SEC
Apr 28, 2026·SEC
Get notified when HCA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HCA Healthcare, Inc. (HCA) stock FAQ — growth, dividends, profitability & financials explained
HCA Healthcare, Inc. (HCA) reported $76.39B in revenue for fiscal year 2025. This represents a 284% increase from $19.91B in 1996.
HCA Healthcare, Inc. (HCA) grew revenue by 7.1% over the past year. This is steady growth.
Yes, HCA Healthcare, Inc. (HCA) is profitable, generating $6.79B in net income for fiscal year 2025 (9.0% net margin).
Yes, HCA Healthcare, Inc. (HCA) pays a dividend with a yield of 0.70%. This makes it attractive for income-focused investors.
HCA Healthcare, Inc. (HCA) generated $7.93B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
